[A long-term follow up study on 345 severe aplastic anemia patients treated with antithymocyte globulin/lymphoglobulin].

Yingqi Shao, Xing-xin Li, Meili Ge, Jun Shi, Jing Zhang, Jinbo Huang, Zhendong Huang, Neng Nie, Yizhou ZhengPubMed 2013

Abstract

(1) The outcome of mSAA was superior to that of VSAA, but the latter was markedly improved in the last 5 years; (2) rATG-F was inferior to rATG-S with regard to 5-year OS; (3) Immunosuppressive treatment with ATG/ALG plus CsA was more effective than ATG/ALG alone; (4) The addition of rhG-CSF to ATG/ALG had no benefit in terms of OS.
BibTeX
@inproceedings{shao2013long,
  author = {Yingqi Shao and Xing-xin Li and Meili Ge and Jun Shi and Jing Zhang and Jinbo Huang and Zhendong Huang and Neng Nie and Yizhou Zheng},
  title = {{[A long-term follow up study on 345 severe aplastic anemia patients treated with antithymocyte globulin/lymphoglobulin].}},
  booktitle = {PubMed},
  year = {2013},
}

Loading related content...

Figure